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Abstract
Background: The increasing mortality rates from alcohol-related liver disease (ARLD) are a public health concern.
To address this, alcohol care teams (ACT) case-find and lead management of alcohol issues for these patients. Local
assessments of ACTs have shown reductions in emergency admissions and emergency department attendances.
We examine the impact of ACTs on emergency hospital activity following a diagnosis of ARLD.
Methods: Administrative Hospital Episode Statistics (HES) data were extracted. Information on ACT provision at
English NHS hospital trusts and sites in 2009/10 was taken from a survey by Public Health England. We undertook
a difference-in-difference analysis to compare emergency hospital activity for a cohort of individuals diagnosed
with ARLD who presented to hospitals either with or without an ACT in the one year before and after a first ARLD
diagnosis during 2009/10.
Results: Over the study period, 9,165 individuals eligible for inclusion in our study had a first diagnosis of ARLD.
4,768 presented to one of 41 hospital trusts with an ACT (59 sites) and 4,397 presented to one of 50 non-ACT
hospital trusts (65 sites). Whilst age and sex demographics were similar between the two cohorts, the ACT
hospital cohort had a higher proportion of individuals in the most deprived quintile (41.6 % v 28.5 % p < .0001).
In the difference-in-difference analysis, the presence of an ACT at a hospital trust was not associated with a
change in all-cause emergency admissions (0.020 (95 % CI −0.070, 0.111), p = 0.656), alcohol-related emergency
admissions (−0.025 (95 % CI −0.104, 0.054), p = 0.536) or all-cause emergency department attendances (0.042
(95 % CI −0.087, 0.171), p = 0.521). Sensitivity analyses by sex and hospital site did not affect the study findings.
Conclusions: In this study, the presence of an ACT at the NHS hospital trust where individuals have their first
recorded diagnosis of ARLD does not appear to be associated with subsequent emergency hospital activity
within these populations. Further analysis focussing on the components and specific effects of ACT interventions
on individuals and systems both pre- and post-diagnosis of ARLD may reveal important avenues to improve care.
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Background
In the United Kingdom, standardised mortality rates
from liver disease have increased 400 % since 1970, and
in patients younger than 65 years have increased by
almost 500 % (from 1.83 per 100,000 in 1970 to 9.46 per
100,000 in 2010) [1]. Consequently, liver disease is the
third biggest cause of premature mortality with 62
000 years of working life lost every year [2]. In England
and Wales 600,000 people have some form of liver dis-
ease of whom 60,000 people have cirrhosis, leading to
57,682 hospital admissions and 10,948 deaths in 2012
[3]. Nearly three-quarters of liver disease mortality is
secondary to excess alcohol use [4] and rates of alcohol
consumption remain a concern [1]. Timely intervention
to reduce alcohol use has the capacity to prevent deteri-
oration in liver disease [5]. A case-control study from
the UK demonstrates that patients with alcoholic liver
cirrhosis have an increased rate of alcohol-related admis-
sions in the year prior to diagnosis compared to the gen-
eral population and therefore there is an opportunity for
preventative interventions in secondary care [6, 7].
According to Public Health England (PHE), 75 % of
England’s hospitals in 2013 had an alcohol care team (ACT).
Approach of these teams vary but roles may include facilita-
tion of case-finding strategies, leading medical management
of patients with alcohol problems, and liaising with com-
munity and secondary care services [8]. Local evaluations
have shown alcohol teams to be effective in terms of redu-
cing emergency admissions, reducing length of stay and
improving quality of life across a range of patient groups
[9–15]. A multi-disciplinary team at a hospital in Salford,
UK, who targeted those with the highest number of alcohol
related admissions saw a reduction in emergency depart-
ment attendances and admissions when comparing the
three months before and after the intervention period [11].
In a pragmatic randomised controlled trial, referral to an al-
cohol health worker at an inner London hospital was asso-
ciated with a mean of 0 · 5 fewer visits to the emergency
department over the following 12 months compared to the
control arm of information alone [15]. However, to date,
there have been no studies that have examined the impact
of alcohol teams on hospital activity using national, admin-
istrative hospital data. The National Confidential Enquiry
on Patient Outcome and Death (NCEPOD) identified op-
portunities to intervene earlier in alcohol-related liver dis-
ease (ARLD) to improve outcomes and we wanted to
explore whether there was population-level evidence that
ACTs were associated with beneficial health effects for
ARLD patients.
Given the national policy emphasis on prevention [16]
and potential challenges of funding preventative services
as a result of fiscal constraints, we were keen to explore
whether there was potential to identify population differ-
ences in emergency hospital activity associated with the
presence of an ACT, using national, administrative data.
Our hypothesis was that presence of ACTs at hospitals
where a first recorded diagnosis of ARLD was made would
be associated with a reduction in emergency hospital
activity when examining the difference in activity before
and after this point in comparison to where there were
no ACTs.
Methods
Identifying ARLD patients
We defined a cohort of individuals from HES (the ad-
ministrative dataset of activity in England’s NHS hospi-
tals) using the unique pseudonymised identifier, aged 15
to 100 years who had a ‘first’ recorded diagnosis (using
all diagnoses recorded) of ARLD (ICD-10 code K70)
during 2009/10 in inpatient or outpatient HES (i.e. no
recorded diagnosis of ARLD from April 2004 to March
2009). We defined the date of this admission or attend-
ance as the index date for each patient.
Assessing the potential impact of hospital alcohol teams
From the Public Health England (PHE) survey of hospital
ACT provision carried out in 2013 [8], 114 services
provided a date when the alcohol service has been set up
(range from 2002 to 2013). We chose to define our cohort
of patients in 2009/10 as approximately half of hospital
ACTs have been set up since that time according to the
PHE survey and offer a sufficient study population for
analysis.
Using this information we identified hospital sites that
had an alcohol service (ACT hospital) in the year of
diagnosis of the ARLD cohort (2009/10), and those
known not to have an alcohol team (non-ACT hospital)
in 2009/10. We assigned ‘unknown’ status where no start
date for the ACT had been reported in the PHE survey.
We linked this information about provision of hospital
ACTs to the cohort of patients who had a first recorded
diagnosis of ARLD in 2009/10. This was based on where
patients had a potential exposure to a hospital ACT
through there being a team in place in the hospital trust
(the organisation which may be a group of hospitals over
several locations, rather than the hospital site which is
the hospital at a single location) where the patient pre-
sented to at the time of their first recorded diagnosis.
This information was used to examine whether provision
of a hospital ACT had any impact upon counts of hospital
activity, specifically emergency admissions and emergency
department attendances for any reason and specifically alco-
hol related emergency admissions (Table 1) in the year fol-
lowing a first recorded diagnosis of ARLD compared to
activity in the preceding year (based upon the index date for
each person). Activity which occurred at any hospital was
included as we considered hospital admission with a first re-
corded diagnosis to be a trigger for on-going individual
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support or behaviour change. This trigger event supported
our choice of a one year before and after time period for
comparison as well as this being informed by published
local evaluations of effective services and in order to contain
uncertainty in attribution of effect to ACT intervention.
We carried out sub-group analyses by examining
whether there were differences in the effect by sex. We
also undertook a sensitivity analysis in which we only
linked provision of a hospital ACT at a specific hospital
site to the patients who had their first recorded diagnosis
of ARLD at that hospital site.
Statistical methods
A three level categorical variable was used to define the
exposure of having the index admission at a trust with an
ACT (has an ACT, no ACT and unknown). We described
the patient characteristics in the ACT and no ACT groups,
specifically, age, sex, ethnicity and deprivation measured
by the proportion of the group in the most deprived 20 %
of the English population (based on Index of Deprivation
2010 scores at lower super output area [17]) according to
the patients place of residence and the proportion who
died in hospital within the one year follow up. We exam-
ined whether there were important socio-demographic
characteristics of the groups using chi-squared tests for
proportions and a t-test for the difference in mean age.
We undertook a difference in difference analysis [18],
using a linear mixed model [19], where we examined the
difference in mean counts of hospital activity for the group
of individuals presenting to hospitals with an ACT in the
one year before diagnosis and compared this to those
without for the same patient cohort in the subsequent
year. This method was chosen to enable an assessment of
the effect of the ACT intervention while overcoming
problems of information bias (improved recording over
time in A&E data is a recognised limitation of this dataset
[20, 21] by using a comparator group, and confounding,
by effectively matching patients to themselves in the year
before and year after measures. The difference in differ-
ence analyses did not require further adjustment for con-
founding factors as this method takes account of time
invariant confounding factors [22]. We would expect age,
sex and deprivation over the two year time period exam-
ined to fall into this category. We included patient as a
random effect to reflect the fact that the prior and subse-
quent hospital activity is correlated within a patient. All
analysis was undertaken using SAS 9.4.
Results
Definition of the ARLD cohort
During 2009/2010, there were 27,450 individuals who
had an admission with a primary or secondary diagnosis
of ARLD on the HES dataset. From this group, 12,334
were excluded as they had previous ARLD activity
(Fig. 1) recorded since April 2004. There were a further
518 exclusions because the patients was aged less than
15 years of age or was not resident in England. This left
a cohort of 14,598 patients who had their first recorded
diagnosis of ARLD during 2009/10.
Definition of ACT service at hospital level
Responses to the PHE survey gathered start dates for 114
alcohol services [8]. Of these, 59 hospital sites, across 41
hospital trusts, had an ACT in place in 2009/10 or earlier
and 65 sites, across 50 hospital trusts, were identified as not
having an ACT service in 2009/10.
Of our 14,598 individuals diagnosed with ARLD in 2009/
10, 4,768 individuals had their first recorded diagnosis at an
ACT hospital, 4,397 at a non-ACT hospital and 5,433 in a
hospital where the ACT service provision was unknown
(Fig. 1). The unknown group were excluded from further
analysis, leaving a cohort of 9,165 individuals with a first
diagnosis of ARLD for analysis in 2009/10 linked to a hos-
pital with known ACT provision.
Table 1 Wholly alcohol attributable ICD-10 codes used to define
alcohol related inpatient activity (alcohol specific conditions)
ICD-10 code Description
E24.4 Alcohol induced pseudo-Cushing’s syndrome
F10 Mental and behavioural disorders due to alcohol
G31.2 Degeneration of nervous system due to alcohol
G62.1 Alcoholic polyneuropathy
G72.1 Alcoholic myopathy
I42.6 Alcoholic cardiomyopathy
K29.2 Alcoholic gastritis
K70 Alcoholic liver disease
K85.2 Alcohol-induced acute pancreatitis
K86.0 Alcohol induced chronic pancreatitis
Q86.0 Fetal alcohol syndrome (dysmorphic)
R78.0 Excess alcohol blood levels
T51.0 Ethanol poisoning
T51.1 Methanol poisoning
T51.9 Toxic effect of alcohol, unspecified
X45 Accidental poisoning by and exposure to alcohol
X65 Intentional self-poisoning by and exposure to alcohol,
undetermined intent
Y15 Poisoning by and exposure to alcohol, undetermined
intent
Y90 Evidence of alcohol involvement determined by blood
alcohol content
Y91 Evidence of alcohol involvement determined by level of
intoxication
Source: Public Health England [27]
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Comparison of the cohorts
The distributions of gender and age were similar
between cohorts within ACT and non-ACT hospital
trusts. There was no difference in one year in-hospital
survival between the groups (Table 2). A greater pro-
portion of individuals in the ACT hospital cohort
were in the most deprived quintile (41.6 % v 28.5 %
p < .0001) (Table 2). Ethnicity was unknown for the
majority of individuals.
We found small differences in the baseline activity in hos-
pitals with and without ACTs (Table 3). In the year before
diagnosis, the average number of (all cause and alcohol
related) emergency admissions per patient was very similar
in ACT and non-ACT hospitals, yet the average number
of all-cause emergency department attendances appeared
higher in the group where an ACT was present (Table 3).
Impact of ACTs on emergency admissions and emergency
department attendances
The difference-in-difference analysis comparing second-
ary care use between the two cohorts is shown in Table 3.
While average emergency admissions, for any cause,
reduced in the year after diagnosis for both the ACT and
non-ACT hospital cohorts, there was no difference in
the size of this reduction between the two groups. The
reduction in the mean number of all-cause emergency
admissions was 0.020 (95 % CI −0.070, 0.111), p = 0.656
smaller in the ACT group.
Fig. 1 Number of cohort who had first recorded diagnosis at a hospital according to provision of an alcohol team
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For alcohol related emergency admissions, there was
also no significant difference in the observed reduction in
mean number during the year after diagnosis between the
ACT and non-ACT groups (−0.025 (95 % CI −0.104,
0.054), p = 0.536).
On average, patients had more all-cause emergency
department attendances in the year following the first
recorded diagnosis of ARLD in the ACT and non-ACT
group. There was no significant difference in the ob-
served increase in mean number during the year after
diagnosis between the ACT and non-ACT groups (0.042
(95 % CI −0.087, 0.171), p = 0.521).
Sensitivity analysis
In a sex-specific sub-analysis, there was no discern-
ible difference in the findings between men and
women for all-cause or alcohol related emergency admis-
sions, or all-cause emergency department attendances
(Appendices 1 and 2).
We carried out a sensitivity analysis in which we only
linked provision of a hospital alcohol team at a specific
hospital site to the patients who had their first recorded
diagnosis of ARLD at that hospital site (Appendix 3). Of
the 14,598 individuals as part of the incident ARLD co-
hort in 2009/10, 1,025 individuals in the cohort had their
first recorded diagnosis at a hospital where an alcohol
team was in place, 1,245 did not and 12,328 were un-
known. The larger unknown group was due to incom-
plete use of site specific codes in the HES dataset.
There was no difference in the size of the reduction in
mean number of emergency admissions (all cause) ob-
served in the year following diagnosis compared to the
year before, between the ACT and non-ACT groups (the
reduction in mean number of all-cause emergency ad-
missions was 0.103 (95 % CI −0.079 to 0.285), p = 0.267
fewer in the ACT group). For alcohol related emergency
admissions, there was no difference in the observed
reduction in the mean number during the year after
diagnosis between the ACT and non-ACT groups
(0.010 (95 % CI −0.150 to 0.169), p = 0.906) in hospital
sites with an ACT. Finally, for all-cause emergency
department attendances, in the year following the first
recorded diagnosis of ARLD the increase from the year
before was unaffected (0.031 (95 % CI −0.229 to 0.291),
p = 0.816) by the presence on an ACT at the hospital
site (Appendix 3).
Table 2 Characteristics of ARLD cohort according to whether they had their first recorded diagnosis at an NHS hospital trust which
had or did not have an alcohol team in 2009/10
Characteristic of ARLD cohort Alcohol team
Yes (n = 4,768) No (n = 4,397) p valuea
Male (%) 3290 (69.0 %) 3057 (69.5 %) 0.5878
Mean (SD) age (years) 53.6 (12.8) 54.2 (12.7) 0.0171
Age range (years) 17–94 18–95
Resident in most deprived quintile of IMD (%) 1983 (41.6 %) 1253 (28.5 %) <0.0001
White British ethnicityb (%) 358 (7.5 %) 448 (10.2 %) <0.0001
Died in hospital during one year follow up 1125 (23.6 %) 1020 (23.2 %) 0.6367
SD standard deviation
aChi squared test for proportions (% male, % in most deprived Index of Multiple Deprivation (IMD) quintile, % White British & % one-year in-hospital mortality)
and t-test for difference in mean age
bEthnicity was unknown for the majority of individuals
Table 3 Difference-in-difference analysis on patients presenting to NHS hospital trusts with alcohol teams compared to NHS hospital
trusts without - Estimated intervention effects for emergency hospital activity in the year before and the year after diagnosis (as mean
per patient)
Hospital trusts with an alcohol team (n = 4768) Hospital trusts with no alcohol team (n = 4397)
One year before
diagnosis (SD)
One year after
diagnosis (SD)
Difference (SE) One year before
diagnosis (SD)
One year
after diagnosis
(SD)
Difference (SE) Difference in
difference
(95 % CI)
P-value
Emergency
admissions (all)
1.666 (1.69) 1.349 (2.31) −0.318 (0.032) 1.691 (1.92) 1.353 (2.37) −0.338 (0.033) 0.020
(−0.070, 0.111)
0.656
Emergency admissions
(alcohol related)
1.301 (1.37) 1.074 (2.01) −0.227 (0.028) 1.283 (1.49) 1.081 (2.04) −0.202 (0.029) −0.025
(−0.104, 0.054)
0.536
Emergency department
attendances (all)
1.437 (3.08) 1.620 (4.72) 0.182 (0.046) 1.117 (2.43) 1.257 (3.31) 0.140 (0.047) 0.042
(−0.087, 0.171)
0.521
Data are mean number per patient (standard deviation) and difference (standard error). P-value is from the linear mixed model. CI confidence interval
Note: The ‘one year before diagnosis’ field includes the index admission which accounts for the mean number of emergency admissions being above one in
this time period
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Discussion
Main findings
This study was the first example of an analysis of the im-
pact of ACTs on emergency hospital activity amongst an
ARLD cohort at a national level using routine administra-
tive datasets. We used the national PHE hospital alcohol
team survey and English NHS hospital episode statistics
to investigate the impact of ACTs on hospital activity for
patients’ before and after diagnosis with ARLD. We pro-
posed that presence of ACTs at hospitals where a first
recorded diagnosis of ARLD was made would be associ-
ated with a reduction in emergency hospital activity when
examining the difference in activity before and after this
point in comparison to where there were no ACTs as a
result of dedicated support to help these patients. However,
using this approach where individuals in the ACT group
may or may not have received the intervention, we did
not find evidence of a change in emergency admissions
(all cause or alcohol related) or all-cause emergency
department attendances between hospitals with an ACT
and those without a service.
Several other local evaluations of hospital alcohol services
have shown ACT’s to be effective in reducing admissions,
bed days, emergency department attendances and quality
of care [9–14]. These evaluations have focused on a single
service and were able to restrict their evaluations to in-
dividuals who had definitely received an ACT interven-
tion. Furthermore, they often used a local database or
audit data to capture hospital activity for the patients
followed up over time. The generalisability of the find-
ings of these single service studies are limited as ACTs
deliver care often designed and applied to the local con-
text. Our current study, by contrast, wanted to assess
the effect of ACTs at a national level in order to provide
support for commissioning of preventative services.
Strengths and limitations
The cohort study design permitted the examination of
ACT effects in a specific high need population. Our study
was also more inclusive than previously published local
evaluations in that it considered all secondary care activity
within hospitals that allowed a comparative study to be
undertaken at a national level and incorporated a robust
statistical method to adjust for confounding factors.
It is important to consider this work in light of some limi-
tations. We used the PHE survey of hospital ACT provision
[8] to determine which individuals in our ARLD cohort
could have potentially received an intervention. We there-
fore did not know which individuals had received an ACT
intervention. This limited the power of the study as it is
reasonable to assume that not every individual presenting
to an ACT hospital would have received an intervention
because of limited capacity or working hours. Defining our
incident ARLD cohort in 2009/10 was useful in that there
was a substantial group of hospitals at this time which did
and which did not have an alcohol team in place. We at-
tributed responsibility for supporting the individual to the
hospital where the patient had their first recorded diagno-
sis. We acknowledge that coding practice may vary between
hospitals and therefore may not be an exact measurement
of the point of diagnosis. This is expected to be a source of
random error in our comparison groups as coding practice
is unlikely to be influenced by the presence of an ACT.
Once the hospital admission or outpatient appointment has
ended, the individual may rely on referral and follow up by
services in the community for on-going support. We had
no information on community or primary care service
provision in this dataset. In addition, where the index ad-
mission was away from a patients usual place of residence,
we had no information to ascertain any follow up arrange-
ments and where links are not in place between services it
is likely that this may have been difficult. This was not
accounted for in our analyses and may have been a factor
in examining the effect of potential intervention by an ACT
given our focus on emergency hospital activity.
From the available data, we were only able to make a di-
chotomous assessment of ACT provision. The PHE survey
had collected some information on the models of alcohol
services provided in hospitals, however, it was difficult to
categorise these services into specific types due to substan-
tial variation in the operational models and due to incom-
plete information. This included, for instance, the number
of whole time equivalent staff in the team, whether a week-
end and evening service was provided, whether the team
was led by a senior clinician, whether the service targeted
patients in emergency departments or specific wards. It was
also possible that services may have evolved over time and
the information in the survey reflected the snapshot in time
when the survey was completed.
For pragmatic reasons, we used 2009/10 as the timepoint
to define when a hospital had an ACT. The retrospective
nature of the PHE survey we used to identify ACT provision
does not allow us to accurately identify if an ACT was active
in a particular hospital over the whole 2009/10 period.
There are a variety of drivers of emergency care activity,
particularly in patients with ARLD. The provision or cessa-
tion of health and community support services within indi-
vidual localities may have affected the results of this study,
but our datasets have not allowed us to take these into ac-
count. However, any impact is likely to have been random
across ACT and non-ACT groups due to multiple factors
influencing local community provision of a service such as
competing needs, priorities and availability of funding.
We have also not considered if the patients have devel-
oped more complex ARLD over time. There are limited
clinical variables in the HES dataset and this has precluded
us from measuring severity of ARLD through the Model
for End-stage Liver Disease [23] or Childs-Pugh [24] scores.
Currie et al. BMC Public Health  (2016) 16:685 Page 6 of 9
Additionally, for those hospitals that we included in our
category as not having a dedicated alcohol team, it is
plausible that frontline staff may have delivered brief inter-
ventions as part of their routine practice. Brief interven-
tions have been shown to be effective [25] and so it is
possible that this may have limited our ability to detect a
difference between the hospitals which did and which did
not have alcohol teams. It is also reasonable to assume
that newly commissioned alcohol services would take
some months to become fully effective as has previously
been recognised [9] and this was not accounted for in the
analysis. There may have been other initiatives which we
have not been able to consider in this analysis.
We used first recorded inpatient admission or out-
patient appointment with an ARLD diagnosis as a proxy
for the date of ARLD diagnosis. We also anticipated that
diagnosis would be a trigger for offering support to the
patient. Ideally, harmful alcohol consumption would be
picked up before this point, however, even if this is the
case, the individuals included in the cohort went on to
receiving a diagnosis of ARLD and so may have benefit-
ted from further support at this point. We recognise that
hospital alcohol teams are unlikely to only focus on pa-
tients who have a diagnosis of ARLD and the patients
that we included in this analysis were therefore at the se-
vere end of the spectrum of alcohol related harm.
Explanation
There are several potential explanations for our findings.
There may have been some important differences
between the ACT hospital and non-ACT hospital co-
horts. A larger proportion of individuals that had their
first recorded ARLD diagnosis at an NHS hospital
trust where an ACT was present were in the most de-
prived quintile of the English population and this may
be an indication of greater need in this group. The
higher all-cause emergency department attendances in
ACT hospital trusts suggests these services were in
areas with greater need. While our analyses accounted
for time invariant confounders in the before and after
measures (this would include deprivation over the two
year period examined), it may have been that provision of
an ACT avoided hospital activity that would otherwise
have occurred in its absence. However, it is plausible that
our measurement of exposure to an ACT was not suitably
precise to detect the true effect of the intervention.
Interestingly, we observed an increase in average all-
cause emergency department attendances per patient in
the year following diagnosis regardless of whether the
patient presented to an ACT or non-ACT hospital. We
have already highlighted that improved recording of
attendances in the A&E HES dataset over the time
period we examined is a recognised limitation of these
data (2,3). We also recognise there is local variation in
coding practice which we would consider to be a source
of random error in the measurement of A&E atten-
dances at both the ‘year before’ and ‘year after’ time
periods. However, it is also possible that this increase
may reflect an increase in health seeking behaviour trig-
gered by diagnosis of ARLD and lack of support or service
provision in the community.
Future work
To overcome some of these challenges in examining the
impact of ACTs within NHS settings on acute care activ-
ity, more precise measurement of exposure to ACT’s is
needed. This could be achieved through working with a
subset of hospitals to obtain details of ACT provision
and use this information to restrict the analyses accord-
ingly. Along with greater certainty of ACT provision, it
may also be possible to gather data of individuals who
received an ACT intervention and link these, maintain-
ing anonymity of individuals, to HES data.
Furthermore, to overcome challenges of potential dif-
ferences in baseline need in ACT and non-ACT groups,
an alternative method, such as a retrospective matched
control method, could be used to generate a matched
control group from the same hospital population as the
cases receiving an ACT intervention (where individuals
who have received the ACT intervention are known).
This method could be applied to replicate and poten-
tially validate findings of a previous local evaluation
demonstrating an effective service.
In order to replicate the methodology of this study
with more precise measurement of exposure to an ACT,
greater granularity is required in hospital data. For in-
stance, a well-designed dataset, with appropriate linkage,
collecting patient level information on when individuals
are referred to a hospital alcohol team (or all substance
misuse services), what intervention was received, the in-
dividuals alcohol consumption status and relevant diag-
noses would facilitate this and ideally should be joined
up with community service provision. Alongside this,
repeated surveys by PHE to monitor the changing pic-
ture of alcohol teams in England’s hospitals and would
enable more in-depth examination of which aspects of
hospital alcohol teams optimise their effectiveness.
Whilst the Five Year Forward View (describing how the
NHS in England needs to change to meet the current chal-
lenges and changing demands, published by NHS England
in 2014) [16] and the Government’s Alcohol Strategy 2012
(setting direction for alcohol policy in England and pub-
lished under the Coalition government) [26] identify the
importance of preventative services, constrained public
health resources will drive the need to demonstrate higher
quality evidence of efficacy. The increasing health and eco-
nomic burden of liver disease [1] in the UK makes this a
key priority for national preventative action.
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Conclusions
In our population level analyses the presence of an ACT
at the NHS hospital trust where individuals had their first
recorded diagnosis of ARLD did not appear to affect, sub-
sequent emergency hospital activity. However this is likely
to be due to a number of methodological challenges and a
lack of patient level data on the ACT intervention. The
evidence of increased liver-related mortality and the bur-
den of alcohol on secondary care utilisation are important
public health concerns. An increased focus on accurate
reporting of the components and specific effects of
ACT interventions on individuals and systems both
pre- and post-diagnosis of ARLD will help build evidence
of effectiveness and share learning across the country.
Table 4 Difference-in-difference analysis on male patients presenting to NHS hospital trusts with alcohol teams compared to NHS
hospital trusts without - Estimated intervention effects for emergency hospital activity in the year before and the year after diagnosis
(as mean per patient)
Hospital sites with an alcohol team (n = 3,290) Hospital sites with no alcohol team (n = 3,057)
One year before
diagnosis (SD)
One year after
diagnosis (SD)
Difference (SE) One year before
diagnosis (SD)
One year after
diagnosis (SD)
Difference (SE) Difference
in difference
(95 % CI)
P-value
Emergency
admissions (all)
1.696 (1.800) 1.398 (2.412) −0.298 (0.040) 1.717 (1.994) 1.401 (2.435) −0.315 (0.042) 0.018
(−0.095 to 0.131)
0.758
Emergency admissions
(alcohol related)
1.340 (1.490) 1.114 (2.096) −0.226 (0.035) 1.316 (1.578) 1.129 (2.146) −0.187 (0.037) −0.039
(−0.139 to 0.060)
0.442
Emergency department
attendances
1.516 (3.353) 1.763 (5.207) 0.247 (0.060) 1.144 (2.518) 1.343 (3.613) 0.199 (0.062) 0.048
(−0.120 to 0.217)
0.575
Data are mean number per patient (standard deviation) and difference (standard error). P-value is from the linear mixed model. CI confidence interval
Note: The ‘one year before diagnosis’ field includes the index admission which accounts for the mean number of emergency admissions being above one in this time period
Appendix 1
Table 5 Difference-in-difference analysis on female patients presenting to NHS hospital trusts with alcohol teams compared to NHS
hospital trusts without - Estimated intervention effects for emergency hospital activity in the year before and the year after diagnosis
(as mean per patient)
Hospital sites with an alcohol team (n = 1,478) Hospital sites with no alcohol team (n = 1,340)
One year before
diagnosis (SD)
One year after
diagnosis (SD)
Difference (SE) One year before
diagnosis (SD)
One year after
diagnosis (SD)
Difference (SE) Difference
in difference
(95 % CI)
P-value
Emergency
admissions (all)
1.600 (1.422) 1.237 (2.072) −0.363 (0.051) 1.631 (1.750) 1.241 (2.205) −0.390 (0.053) 0.028
(−0.116 to 0.172)
0.707
Emergency admissions
(alcohol related)
1.214 (1.067) 0.984 (1.789) −0.229 (0.044) 1.208 (1.250) 0.972 (1.782) −0.237 (0.046) 0.007
(−0.118 to 0.133)
0.910
Emergency department
attendances
1.263 (2.334) 1.301 (3.354) 0.038 (0.062) 1.054 (2.200) 1.060 (2.482) 0.006 (0.065) 0.032
(−0.145 to 0.209)
0.724
Data are mean number per patient (standard deviation) and difference (standard error). P-value is from the linear mixed model. CI confidence interval
Note: The ‘one year before diagnosis’ field includes the index admission which accounts for the mean number of emergency admissions being above one in
this time period
Table 6 Difference-in-difference analysis on patients presenting to NHS hospital sites with alcohol teams compared to NHS hospital trusts
without - Estimated intervention effects for emergency hospital activity in the year before and the year after diagnosis (as mean per patient)
Hospital trusts with an alcohol team (n = 1025) Hospital trusts with no alcohol team (n = 1245)
One year before
diagnosis (SD)
One year after
diagnosis (SD)
Difference (SE) One year before
diagnosis (SD)
One year after
diagnosis (SD)
Difference (SE) Difference
in difference
(95 % CI)
P-value
Emergency
admissions (all)
1.628 (1.769) 1.375 (2.496) −0.254 (0.069) 1.696 (1.945) 1.340 (2.390) −0.357 (0.062) 0.103
(−0.079 to 0.285)
0.267
Emergency admissions
(alcohol related)
1.270 (1.390) 1.057 (2.077) −0.214 (0.060) 1.296 (1.538) 1.072 (2.157) −0.223 (0.055) 0.010
(−0.150 to 0.169)
0.906
Emergency department
attendances
1.693 (3.834) 1.736 (4.864) 0.043 (0.098) 1.589 (2.917) 1.601 (4.099) 0.012 (0.089) 0.031
(−0.229 to 0.291)
0.816
Data are mean number per patient (standard deviation) and difference (standard error). P-value is from the linear mixed model. CI confidence interval
Note: The ‘one year before diagnosis’ field includes the index admission which accounts for the mean number of emergency admissions being above one in
this time period
Appendix 3
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